SenoRx is committed to supporting physicians in their efforts to eradicate breast disease. With a focus on innovation, SenoRx has developed industry-leading minimally invasive devices that have significantly improved patient outcomes at every step of the diagnostic and treatment pathway. Leading breast care providers have recognized the effectiveness of SenoRx products via publications and numerous presentations at major congresses. And to date 41 U.S. patents have been awarded to the SenoRx research team for their technological breakthroughs, and 60 U.S. patents are pending.